We are live on ! Find out more
AGM

Alpine Global Management Portfolio holdings

AUM $668M
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+14.93%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$301M
AUM Growth
-$127M
Cap. Flow
-$134M
Cap. Flow %
-44.67%
Top 10 Hldgs %
57.1%
Holding
842
New
352
Increased
28
Reduced
90
Closed
287

Sector Composition

Rank Sector Weight
1 Healthcare 18.53%
2 Technology 13.41%
3 Financials 12.89%
4 Consumer Discretionary 7.02%
5 Industrials 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AONCW
601
DELISTED
American Oncology Network, Inc. Warrant
AONCW
-50,000
Closed -$4K
QDROW
602
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$0 ﹤0.01%
17,125
PMGMW
603
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
-57,762
Closed -$6K
CONX
604
DELISTED
CONX Corp. Class A Common Stock
CONX
-83,595
Closed -$836K
AEON.WS
605
DELISTED
AEON Biopharma Inc
AEON.WS
-50,100
Closed -$3K
RMGCW
606
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$0 ﹤0.01%
10,515
STIXW
607
DELISTED
Semantix, Inc. Warrant
STIXW
-130,647
Closed -$14K
GAQ.WS
608
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
-50,300
Closed -$4K
ASCAW
609
DELISTED
A SPAC I Acquisition Corp. Warrant
ASCAW
-50,000
Closed -$2K
PORT.WS
610
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
-56,700
Closed -$6K
PEPLW
611
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
-50,600
Closed -$3K
HCMAW
612
DELISTED
HCM Acquisition Corp Warrant
HCMAW
-54,500
Closed -$4K
TGVCW
613
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
-52,140
Closed -$3K
VAQC
614
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
-18,565
Closed -$184K
RCACW
615
DELISTED
Revelstone Capital Acquisition Corp. Warrant
RCACW
-50,300
Closed -$5K
ACAHW
616
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
-56,500
Closed -$2K
FICVW
617
DELISTED
Frontier Investment Corp Warrants
FICVW
-51,700
Closed -$2K
OPA.WS
618
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
-190,108
Closed -$32K
NCACW
619
DELISTED
Newcourt Acquisition Corp Warrant
NCACW
$0 ﹤0.01%
13,415
OTECW
620
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
-53,657
Closed -$5K
CSTA.WS
621
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
-57,000
Closed -$1K
LMDXW
622
DELISTED
LumiraDx Limited Warrant
LMDXW
-64,024
Closed -$7K
JAQCW
623
DELISTED
Jupiter Acquisition Corporation Warrants
JAQCW
-50,200
Closed -$6K
DISAW
624
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
-58,400
Closed -$2K
LVOX
625
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
-18,193
Closed -$54K

Similar funds

Alpine Global Management's Q4 2022 Portfolio in Review

As of Q4 2022, Alpine Global Management held 842 positions worth $301M, down 30% from $427M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Alpine Global Management withdrew a net $134M in Q4 2022, closing 287 positions and reducing 90 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $56.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

Against the trend, Alpine Global Management opened a new position in Tesla worth $9.84M.

  • Alpine Global Management's largest Q4 2022 buy was Tesla: 79,871 shares worth $9.84M.
  • Alpine Global Management added most to Cornerstone Strategic Value Fund in Q4 2022, an estimated $9.51M increase.
  • Alpine Global Management's biggest Q4 2022 reduction was Immunovant, cutting an estimated $35.9M.
  • Alpine Global Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $56.5M.
  • Alpine Global Management's ten largest holdings make up 57% of its $301M portfolio in Q4 2022.
  • Alpine Global Management opened 352 new positions and closed 287 in Q4 2022.
  • Alpine Global Management's portfolio value fell 30% quarter-over-quarter to $301M.

Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.